Bacteria and endotoxins in IV therapy can compromise patient safety and treatment outcomes. To address this, we manufacture and validate intravenous filters with a positively charged membrane with a claim for the removal of bacteria and associated endotoxins for up to 96 hours. Our in-line IV filters integrating Posidyne™ membrane retain endotoxins in both clinical and laboratory settings, supporting reliable infusion safety over an extended period.

It is widely accepted by regulatory authorities that intravenous solutions administered in to a patient's bloodstream must be endotoxin-free or 'pyrogen free', so regardless of the patient's status, they should be protected against exogenous endotoxin released by Gram-negative bacteria. Our in-line IV filters with Posidyne membrane are able to remove endotoxins up to 96  hours.

Implementing IV filtration can be complex. Our Clinical Specialist Team provides hands-on support before, during, and after installation, from bedside evaluations to infusion training. With clear instruction and real-time troubleshooting, we help staff build confidence, reduce risk, and ensure safer IV therapy for patients worldwide.